W. P. Carey Inc. (LON:0LS8)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 11.86B +9.1% |
| Revenue (ttm) | 1.37B +11.3% |
| Net Income | 490.66M +93.9% |
| EPS | 2.20 +92.1% |
| Shares Out | n/a |
| PE Ratio | 24.17 |
| Forward PE | 24.82 |
| Dividend | 2.78 (5.30%) |
| Ex-Dividend Date | Jun 30, 2026 |
| Volume | 176 |
| Open | 71.00 |
| Previous Close | 70.52 |
| Day's Range | 70.26 - 71.14 |
| 52-Week Range | 63.19 - 77.80 |
| Beta | 0.78 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 29, 2026 |
About W. P. Carey
W. P. Carey Inc. ranks among the largest net lease REITs with a well-diversified portfolio of high-quality, operationally critical commercial real estate. It includes 1,748 net lease properties covering approximately 188 million square feet as of June 30, 2026. With offices in New York, London, Amsterdam and Dallas, the company remains focused on investing primarily in single-tenant, industrial, warehouse and retail properties located in the U.S. and Europe, under long-term net leases with built-in rent escalations. W. P. Carey Inc. was incorpo... [Read more]
Financial Performance
In 2025, W. P. Carey's revenue was $1.71 billion, an increase of 8.20% compared to the previous year's $1.58 billion. Earnings were $466.36 million, an increase of 1.20%.
Financial numbers in USD Financial StatementsNews
W.P. Carey upgraded to Equal Weight from Underweight at Barclays
Barclays upgraded W.P. Carey (WPC) to Equal Weight from Underweight with an unchanged price target of $80. The firm is making a relative valuation call with the upgrade. It expects…
W.P. Carey price target raised to $77 from $76 at Scotiabank
Scotiabank analyst Greg McGinniss raised the firm’s price target on W.P. Carey (WPC) to $77 from $76 and keeps a Sector Perform rating on the shares. The company increased its…
W.P. Carey price target raised to $84 from $83 at BofA
BofA raised the firm’s price target on W.P. Carey (WPC) to $84 from $83 and keeps a Neutral rating on the shares. The firm adjusted several net lease REIT targets…
W.P. Carey price target raised to $77 from $75 at Evercore ISI
Evercore ISI raised the firm’s price target on W.P. Carey (WPC) to $77 from $75 and keeps an In Line rating on the shares.
W.P. Carey price target raised to $77 from $73 at RBC Capital
RBC Capital raised the firm’s price target on W.P. Carey (WPC) to $77 from $73 and keeps a Sector Perform rating on the shares. The company’s Q2 results were solid,…
W. P. Carey Earnings Call Transcript: Q2 2026
AFFO per share rose 4.7% year-over-year in Q2 2026, driven by strong investment activity and sector-leading rent growth. Guidance for full-year AFFO and investment volume was raised, with ample liquidity and minimal risk from Hellweg. Portfolio occupancy improved to 98.5%.
W. P. Carey Earnings release: Q2 2026
W. P. Carey released its Q2 2026 earnings on July 29, 2026, summarizing the period's financial results.
W. P. Carey Slides: Q2 2026
W. P. Carey has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 29, 2026.
W. P. Carey Quarterly report: Q2 2026
W. P. Carey has published its Q2 2026 quarterly earnings report on July 29, 2026.
W.P. Carey upgraded to Outperform from Neutral at BNP Paribas
BNP Paribas upgraded W.P. Carey (WPC) to Outperform from Neutral with an $88 price target
W. P. Carey Announces Second Quarter 2026 Financial Results
NEW YORK, July 28, 2026 /PRNewswire/ -- W. P. Carey Inc. (NYSE: WPC) (W.
W.P. Carey price target raised to $80 from $78 at Barclays
Barclays analyst Richard Hightower raised the firm’s price target on W.P. Carey (WPC) to $80 from $78 and keeps an Underweight rating on the shares. The firm adjusted targets in…
W. P. Carey Earns 2026 Great Place to Work Certification™ in the U.S., the Netherlands and the U.K.
Also Named One of Fortune's Best Workplaces in New York™ for the Third Consecutive Year NEW YORK, July 13, 2026 /PRNewswire/ -- W. P. Carey Inc. (W.
W. P. Carey to Release Second Quarter 2026 Financial Results on Tuesday, July 28, 2026
Conference Call Scheduled for Wednesday, July 29, 2026 at 11:00 a.m. Eastern Time NEW YORK, July 7, 2026 /PRNewswire/ -- W.
W. P. Carey Releases 2025 Corporate Responsibility Report
NEW YORK, July 6, 2026 /PRNewswire/ -- W. P. Carey (W.
W. P. Carey Announces Pricing of $350 Million of Senior Unsecured Notes
NEW YORK, June 29, 2026 /PRNewswire/ -- W. P. Carey Inc. (NYSE: WPC, the "Company") announced today that it has priced an underwritten public offering of $350 million aggregate principal amount of 5.2...
There's Big Money to Be Made in European Real Estate
His grandfather ran on Nixon's ticket. Now he's got his own fixed-income investing tricks.
W.P. Carey price target lowered to $84 from $86 at BMO Capital
BMO Capital analyst John Kim lowered the firm’s price target on W.P. Carey (WPC) to $84 from $86 and keeps an Outperform rating on the shares. The firm cites the…
W.P. Carey price target lowered to $76 from $79 at Scotiabank
Scotiabank lowered the firm’s price target on W.P. Carey (WPC) to $76 from $79 and keeps a Sector Perform rating on the shares. The firm sees real estate investment trust…
W.P. Carey price target lowered to $84 from $86 at BMO Capital
BMO Capital analyst John Kim lowered the firm’s price target on W.P. Carey (WPC) to $84 from $86 and keeps an Outperform rating on the shares. The firm is citing…
W.P. Carey upgraded to Neutral from Underperform at BofA
BofA upgraded W.P. Carey (WPC) to Neutral from Underperform with a price target of $83, up from $73.
W.P. Carey upgraded to Neutral from Underperform at BofA
BofA upgraded W.P. Carey (WPC) to Neutral from Underperform with a price target of $83, up from $73. The firm believes W.P. Carey warrants a higher multiple given its improved…
W. P. Carey Increases Quarterly Dividend to $0.940 per Share
NEW YORK, June 11, 2026 /PRNewswire/ -- W. P. Carey Inc. (W.
W. P. Carey Transcript: Nareit REITweek: 2026 Investor Conference
Guidance was raised on the back of strong investment activity, especially in industrial and European assets, and improved rent loss outlook. The portfolio remains resilient, with reduced exposure to riskier tenants and a focus on inflation-linked leases. Funding is secured for future investments, supporting continued growth.
Ono Pharma Announces Poster Presentation of New Clinical Data from Phase 2 Study of ONO-2808 (S1P5 Receptor Agonist) in Multiple System Atrophy at the 7th World Parkinson Congress (WPC)
OSAKA, Japan--(BUSINESS WIRE)--Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”) announced the presentation of data from the randomized, double-blind, ...